ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	8/50	56/7206	3.30687368962e-09
ko04728	Dopaminergic synapse	10/50	185/7206	4.10988938025e-07
ko04713	Circadian entrainment	8/50	136/7206	3.60660869894e-06
ko04730	Long-term depression	6/50	78/7206	1.44087796401e-05
ko04080	Neuroactive ligand-receptor interaction	12/50	423/7206	2.25658622113e-05
ko04723	Retrograde endocannabinoid signaling	8/50	175/7206	2.31692438051e-05
ko05031	Amphetamine addiction	6/50	91/7206	3.49238621904e-05
ko04720	Long-term potentiation	6/50	99/7206	5.6292286899e-05
ko04724	Glutamatergic synapse	7/50	152/7206	7.5529652591e-05
ko04721	Synaptic vesicle cycle	5/50	80/7206	0.000213054964248
ko04727	GABAergic synapse	5/50	110/7206	0.000927966312473
ko04911	Insulin secretion	5/50	117/7206	0.00122497155396
ko04010	MAPK signaling pathway	8/50	321/7206	0.00148349336409
ko05030	Cocaine addiction	4/50	73/7206	0.00157012496153
ko05014	Amyotrophic lateral sclerosis (ALS)	4/50	74/7206	0.00165142955781
ko04020	Calcium signaling pathway	7/50	265/7206	0.0021651177214
ko04015	Rap1 signaling pathway	7/50	278/7206	0.002837481085
ko04024	cAMP signaling pathway	7/50	279/7206	0.00289519405025
ko04925	Aldosterone synthesis and secretion	4/50	105/7206	0.00586234340598
ko05032	Morphine addiction	4/50	110/7206	0.00690315370631
ko02025	Biofilm formation - Pseudomonas aeruginosa	1/50	1/7206	0.00693866222591
ko04961	Endocrine and other factor-regulated calcium reabsorption	3/50	59/7206	0.00777932105972
ko04540	Gap junction	4/50	128/7206	0.0116469785486
ko04970	Salivary secretion	3/50	95/7206	0.0278455984322
ko04971	Gastric acid secretion	3/50	98/7206	0.0301608241456
ko04960	Aldosterone-regulated sodium reabsorption	2/50	41/7206	0.0325771465137